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ABSTRACT Coronavirusesefﬁcientlyinhibitinterferon(IFN)inductioninnonhematopoieticcellsandconventionaldendriticcells
(cDC).However,IFNisproducedininfectedmacrophages,microglia,andplasmacytoiddendriticcells(pDC).Tobegintounderstand
whyIFNisproducedininfectedmacrophages,weinfectedbonemarrow-derivedmacrophages(BMM)andasacontrol,bonemarrow-
derivedDC(BMDC)withthecoronavirusmousehepatitisvirus(MHV).Asexpected,BMMbutnotBMDCexpressedtypeIIFN.IFN
productionininfectedBMMwasnearlycompletelydependentonsignalingthroughthealpha/betainterferon(IFN-/)receptor
(IFNAR).SeveralIFN-dependentcytokinesandchemokinesshowedthesameexpressionpattern,withenhancedproductioninBMM
comparedtoBMDCanddependenceuponsignalingthroughtheIFNAR.ExogenousIFNenhancedIFN-dependentgeneexpressionin
BMMatearlytimesafterinfectionandinBMDCatalltimesafterinfectionbutdidnotstimulateexpressionofmoleculesthatsignal
throughmyeloiddifferentiationfactor88(MyD88),suchastumornecrosisfactor(TNF).Collectively,ourresultsshowthatIFNispro-
ducedatearlytimespostinfection(p.i.)inMHV-infectedBMM,butnotinBMDC,andprimesexpressionofIFNandIFN-responsive
genes.Further,ourresultsalsoshowthatBMMaregenerallymoreresponsivetoMHVinfection,sinceMyD88-dependentpathways
arealsoactivatedtoagreaterextentinthesecellsthaninBMDC.
IMPORTANCE Coronavirusescausediseaseswithvariousdegreesofseverityinhumans,includingsevereacuterespiratorysyn-
drome(SARS).Indomesticandcompanionanimals,coronavirusesinduceinterferon(IFN)inonlyafewcelltypes.Inparticular,
macrophages,whichareknowntohavebothprotectiveandpathogenicrolesincoronavirusinfections,expressIFNwhileden-
driticcellsdonot.Littleisknownaboutthebasisofthesecell-speciﬁcdifferencesinIFNinduction.Here,weshowthatanani-
malcoronavirus,mousehepatitisvirus,inducesIFNandotherIFN-responsivemoleculesinmacrophages,butnotindendritic
cells,viaafeedbackloopthatisdependentuponlow-levelIFNexpressionatearlytimesafterinfection.Thispathwayofcellular
activationmaybeausefultargetformodulatingmacrophagefunctioninordertoselectivelyenhancetheantivirusimmunere-
sponseanddiminishthepathogenicroleofthesecellsinSARSandothercoronavirusinfections.
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T
ype I interferon (IFN), alpha/beta interferon (IFN-/), plays a
critical role during the initial antivirus immune response. Type I
IFNs directly inhibit viral replication by creating an “antiviral state”
by upregulating interferon-responsive genes, such as the genes en-
coding 2=,5=-oligoadenylate synthetase, RNase L, and Mx protein,
and they are also critical for activating and regulating the adaptive
immune response (1, 2). The importance of the type I IFN response
duringviralinfectionisreﬂectedbythefactthatmostvirusesexpress
IFNantagoniststhatareabletosuppressIFNpathwaysatthelevelof
IFN production or signaling or that directly interact with antiviral
IFN-responsive genes (reviewed in references 3 to 5). Type I IFN
production is initiated after recognition of pathogen-associated mo-
lecular patterns (PAMPs), such as viral double-stranded RNA
(dsRNA),byhostcellpathogenrecognitionreceptors(PRRs).There
aretwomajortypesofPRRsthatinduceIFNproduction,cytoplasmic
RNA helicases, including retinoic acid-inducible gene I product
(RIG-I) and melanoma differentiation-associated gene 5 product
(MDA5),andToll-likereceptors(TLRs),includingToll-likereceptor
2 (TLR2), TLR3, TLR4, TLR7, TLR8, and TLR9 (6). Almost all cells
express type I IFN receptor, which allows them to respond to IFN,
and are able to produce various amounts of type I IFN during viral
infections.Inparticular,plasmacytoiddendriticcells(pDC)produce
large amounts of alpha interferon (IFN-) during early stages of the
inﬂammatory response. Conventional dendritic cells (cDC) and
macrophagesalsoexpresstypeIIFN,althoughnottothesameextent
as pDC do (7).
Coronaviruses are large, positive-sense, single-stranded RNA
viruses that cause clinically signiﬁcant diseases in humans and
domestic and companion animals (8). All coronaviruses encode
four or ﬁve structural proteins, approximately 16 replicase-
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interspersed between or within structural proteins encoded at the
3= end of the genome). SARS-CoV (severe acute respiratory syn-
drome coronavirus) accessory proteins ORF3b and ORF6, mouse
hepatitisvirus(MHV)accessoryproteinORF5a,MHVandSARS-
CoV nucleocapsid (N) proteins and replicase-associated non-
structural protein 1 (nsp1) and nsp3 are all able to inhibit IFN
induction and/or signaling (9–15) (reviewed in reference 16). In
addition, MHV delays IFN-stimulated gene (ISG) induction by
IFN or Sendai virus (SenV) (17). Further, in some cell types, in-
cluding ﬁbroblasts and cDC, neither SARS-CoV nor MHV in-
duces IFN expression. However, neither virus is able to prevent
IFN induction by other viruses or by poly(I · C), which suggests
that these viruses are “invisible” to intracellular IFN sensors (18,
19).This“passive”methodofimmuneevasionmayoccurbecause
coronaviruses replicate on membranous structures, including
double-membrane vesicles, thereby limiting exposure of seques-
tered RNA to innate immune sensors (18–20). On ﬁrst glance,
these results appeared to contradict the observation that type I
IFNs are detected in MHV-infected mice and in patients with
SARS (21, 22). However, IFN is induced in pDC by a TLR7- and
interferonregulatoryfactor7(IRF7)-dependentpathway,inmac-
rophages and microglia in an MDA5-dependent pathway, and in
oligodendrocytecelllinesviaMDA5-andRIG-I-dependentpath-
ways (23–25). Collectively, these results show that coronaviruses
use multiple approaches to evade the innate immune response
and that the extent and nature of evasion are cell type dependent.
The basis of these cell type-speciﬁc differences in IFN expression
after coronavirus infection is not well understood.
Both macrophages, in which IFN is induced, and DC, in which
IFN is not induced, are important target cells for several coronavi-
ruses.DCinparticulararecriticalforinitiationoftheantivirusT-and
B-cell responses, which are ultimately critical for virus clearance. In-
fectionofDCandmacrophageslikelycontributestothedevelopment
of effective innate and adaptive immune responses, but macrophage
infection, in the case of some coronaviruses, also contributes to im-
munopathological disease and enhanced lethality (26, 27). Macro-
phage infection has been demonstrated in infected humans or ani-
mals (28–30), and both types of cells are readily infected with
coronaviruses after culture in vitro (24, 31, 32).
Here, we cultured primary bone marrow (BM) cells in vitro in
the presence of cytokines and growth factors, resulting in differ-
entiation into cells with the characteristics of macrophages
(BMM, cultured in the presence of macrophage colony-
stimulating factor [M-CSF]; CD11b CD11c) or dendritic cells
(BMDC, cultured in the presence of granulocyte-macrophage
colony-stimulating factor [GM-CSF] and interleukin-4 [IL-4];
CD11b CD11c). Using these cells, we showed that most of the
IFN produced after MHV infection was dependent on signaling
through the IFN-/ receptor (IFNAR). This IFN was critical for
virus-induced upregulation of several IFN-related molecules, in-
cluding MDA5, RIG-I, and CXCL10 (chemokine [C-X-C motif]
ligand 10). Further, levels of type I IFN produced in MHV-
infectedBMMweresufﬁcienttoinducemaximalactivation,since
exogenous type I IFN treatment did not further stimulate IFN-
related gene upregulation at late times postinfection (p.i.). Our
results also showed that the expression of some inﬂammation-
associated molecules, most notably tumor necrosis factor (TNF),
IL-12,andIL-6,wasmediated,inlargepart,viasignalingthrough
myeloid differentiation factor 88 (MyD88)-dependent pathways.
RESULTS
MHV-infected BMM produce type I IFN at late times p.i. We
previouslyshowedthatneitherBMDCnorﬁbroblastsproducetypeI
IFNafterinfectionwiththeJHMstrainofMHV(JHMV),andothers
have found similar results using the A59 strain (MHV-A59) (18, 19,
23,33).Fortheexperimentsdescribedhere,weusedonlyMHV-A59
(MHV) because this virus grows to high titer and forms syncytia at
later times postinfection (p.i.) than JHMV, allowing prolonged cell
survival. Roth-Cross et al. showed that BMM produced type I IFN
afterMHVinfection,butonlylatetimesp.i.(24hp.i.)wereexamined
inthatinitialstudy(24).TodeterminethekineticsofIFNexpression,
we infected BMM or BMDC with MHV and then measured IFN-
mRNA and IFN protein levels at different times p.i. by real-time
quantitative PCR (qPCR) and by an IFN bioassay, respectively. Sen-
dai virus (SenV) was included as a positive control, since it is known
toinduceIFN.SenV-infectedBMMrapidlyupregulatedIFNexpres-
sionwithproteindetectedasearlyas2hp.i.,andpeaklevelsobserved
atapproximately8hp.i.(Fig.1A).Incontrast,MHV-infectedBMM
producedIFNmuchmoreslowlywithlevelsofIFN-mRNAorIFN
protein barely detectable at 8 h p.i. Peak levels of IFN- mRNA and
protein were reached at 16 to 24 h p.i. (Fig. 1A to C). Maximal IFN
protein levels were approximately 20- to 25-fold lower in MHV-
infected cells than in SenV-infected cells (Fig. 1A and B). Although
theIFNproteinlevelsweremuchlowerinMHV-infectedBMMthan
in SenV-infected cells, IFN- mRNA levels were higher in MHV-
infectedcells(Fig.1AtoC;seealsoFig.3CandE).Thislikelyresulted
from MHV-mediated inhibition of host cell translation, observed in
MHV-infected ﬁbroblasts (11, 14, 34, 35). Consistent with previous
ﬁndings (23, 32, 33), we detected less than 3 U/ml of IFN in MHV-
infected DC at 24 h p.i. (Fig. 1B). These results did not reﬂect differ-
ences in the ability of the two cell types to produce IFN, because DC
rapidlyproducedIFNafterSenVinfectionandpeakIFNproteinlev-
FIG 1 Mouse hepatitis virus (MHV)-infected bone marrow-derived macro-
phages(BMM)producetypeIIFNatlatetimesp.i.(A)BMMorbonemarrow-
derived dendritic cells (BMDC) were infected with MHV or Sendai virus
(SenV), and IFN protein levels were determined using a VSV-based IFN bio-
assayattheindicatedtimes(inhours)postinfection(p.i.).BMM-MHV,BMM
infected with MHV; BMDC-MHV, BMDC infected with MHV. (B) MHV-
inducedIFNproductioninpanelAisshownusinganenlargedscale.(C)BMM
were infected with MHV or SenV, and IFN- mRNA levels were measured by
real-time qPCR. Cycle threshold (CT) values were calculated as a ratio to hy-
poxanthine phosphoribosyltransferase (HPRT) as described in Materials and
Methods. (D) MHV titers in supernatants were determined as previously de-
scribed (52). Two or three replicates were performed in each experiment, and
one of three independent experiments is shown.
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(Fig. 1A). Of note, both BMM and BMDC were readily infected by
MHV, although virus replication proceeded more rapidly in BMM,
with syncytium formation detected as early as 6 h p.i. and peak viral
titers observed at 8 to 12 h p.i. MHV reached maximal virus titers in
BMDC that were approximately 1 log unit higher than in BMM
(Fig. 1D).
MHV-inducedupregulationoftypeIIFN,MDA5,andRIG-I
in BMM is dependent on IFNAR. To begin to investigate why
BMM but not BMDC produced IFN after MHV infection, we
examined the levels of MDA5, since this intracellular helical sen-
sor is required for IFN induction in BMM (24). Basal levels of
MDA5mRNAinmock-infectedBMMwereapproximately2-fold
higherthaninBMDC(Fig.2A).AfterinfectionwithMHV,MDA5
levelswereupregulatedwithsimilarkineticsinBMMandBMDC;
however, levels in BMM were about 20 to 30 times higher than in
BMDC at 24 h p.i. (Fig. 2B and C). Similar changes in expression
of a second intracellular sensor molecule, RIG-I, were also ob-
served. RIG-I is not believed to be critical for IFN production in
MHV-infected BMM, although it has an important role in cells
such as oligodendrocytes (25).
TypeIIFNmediatesenhancedexpressionofMDA5andRIG-I
(36). Thus, elevated baseline levels of MDA5 and RIG-I in MHV-
infectedBMM(Fig.2A)mightfacilitateenhancedIFNproduction
atearlytimesp.i.,whichcouldthenresultinincreasedMDA5and
RIG-IexpressionaftersignalingthroughIFNAR.Toexaminethis
possibility, we cultured BMM from wild-type and IFNAR/
mice. We included BMM from MyD88/ mice in these experi-
ments,sinceMyD88isinvolvedinsignalingthroughTLRsbutnot
IFNAR.WedetectedlowbasallevelsofIFN,MDA5,andRIG-Iin
BMMfromallmice,althoughthelevelswerelowestinIFNAR/
BMM (Fig. 3B). The levels of IFN-, MDA5, and RIG-I mRNA
weresigniﬁcantlylowerininfectedIFNAR/BMMthaninwild-
type BMM (Fig. 3C). However, the mRNA levels of these mole-
cules in infected IFNAR/ BMM were still higher than in mock-
infected IFNAR/ cells (Fig. 3B and C), indicating that virus
infection directly upregulates IFN-, MDA5, and RIG-I, but op-
timal induction requires signaling through the IFNAR. These dif-
ferences did not result from differences in susceptibility to infec-
tion because equivalent titers of virus were observed in
IFNAR/, MyD88/, and wild-type (WT) BMM at 16 h p.i.
(Fig. 3A). Of note, MHV titers are much higher in tissues of
IFNAR/ mice than in wild-type mice. The lack of difference in
titers in Fig. 3A may reﬂect the high multiplicity of infection that
we used in our experiments or the well-described relative insensi-
tivity of MHV to IFN signaling in tissue culture cells (13, 14, 37).
MHV induces IFN production in pDC through a TLR7-
dependent pathway, which signals through MyD88. TLR7 is also
expressed in BMM (38). However, we found that type I IFN pro-
ductioninMHV-infectedBMMwasnotdependentonMyD88in
agreementwithapreviousreport(24)(Fig.3C).Further,thelevels
of MDA5 and RIG-I in MyD88/ BMM were approximately
equal to those found in WT cells, indicating that regulation of
FIG 2 MHV upregulates MDA5 and RIG-I expression to higher levels in
BMM than in BMDC. (A) Basal mRNA levels of MDA5 and RIG-I in mock-
infected BMM and BMDC were measured by real-time qPCR. Values that are
signiﬁcantly different (P  0.05) from the value for BMM are indicated by an
asterisk. (B and C) mRNA levels of MDA5 and RIG-I in BMM (B) and in
BMDC (C) at different times p.i. were measured by real-time qPCR. CT ratios
to HPRT were calculated as described in Materials and Methods. MDA5 and
RIG-I were upregulated to a greater extent in BMM than in BMDC (note the
differences in scale). Two or three replicates were performed in each experi-
ment, and one of three independent experiments is shown.
FIG 3 MHV-induced upregulation of IFN-, MDA5, and RIG-I in BMM is
dependent on IFN-/ receptor (IFNAR). BMM isolated from WT,
IFNAR/, or MyD88/ mice were infected with MHV (A and C) or SenV
(E)ortransfectedwithpoly(I·C)(D).(A)MHVtitersweredeterminedincell
supernatantsat16hourspostinfectionasdescribedinMaterialsandMethods.
(B) mRNA was harvested from mock-infected BMM, and basal levels of
IFN-, MDA5, and RIG-I were measured by real-time qPCR. (C to E) mRNA
washarvested16hafterinfectionortransfection.mRNAlevelsweremeasured
byreal-timeqPCR.CTratiostoHPRTareshown.MHVinducedupregulation
toagreaterextentthanpoly(I·C)orSenVdid(notethedifferencesinscalein
panelsBtoE).Twoorthreereplicateswereperformedineachexperiment,and
one of three independent experiments is shown. Values for IFNAR/ or
MyD88/ BMM that were statistically signiﬁcantly different from the values
for wild-type cells are indicated as follows: *, P  0.05; **, P  0.01.
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(Fig. 3C). These ﬁndings are not unique for MHV, since expres-
sion of IFNAR, but not MyD88, was also required for expression
of IFN-, MDA5, and RIG-I in BMM that were either transfected
with poly(I · C) (Fig. 3D) or infected with SenV (Fig. 3E).
MHV infection results in upregulation of IFN-dependent and
-independent cytokines and chemokines to a greater extent in
BMMthaninBMDC.MHVinfectioninducesexpressionofanarray
of cytokines and chemokines in the infected murine central nervous
system (CNS), including CXCL10, CCL2 (chemokine [C-C motif]
ligand2),TNF,IL-6,IL-10,andIL-12,whichplayimportantrolesin
the anti-MHV immune response (39, 40). We next examined
whetherBMMproducedthesecytokinesandchemokinesafterMHV
infection and, if so, whether their expression depended upon type I
IFN production. We found that these genes were upregulated with
similar kinetics in BMM and BMDC; however, BMM expressed
muchhigherlevelsthanBMDCdid(Fig.4A)(dataforIL-6andIL-10
arenotshown).TheseresultswereconﬁrmedforTNF,CXCL10,and
IL-12 p70 at the protein level by performing an enzyme-linked im-
munosorbentassay(ELISA)(Fig.4CandD).NoIL-12p70mRNAor
protein was detected in BMDC. Of note, basal mRNA levels of
CXCL10 and TNF were higher in BMM than in BMDC, while the
reverse was true for CCL2 (Fig. 4B). Nevertheless, all three were ex-
pressed at higher levels in BMM during the peak time of infection
(Fig.4A),indicatingthatthedifferencesinbasallevelsdidnotexplain
the ability of BMM to produce larger amounts of inﬂammatory cy-
tokines and chemokines in response to MHV infection.
To assess whether the upregulation of these cytokines and
chemokines was IFN dependent, we analyzed only BMM, since
BMDC produced very low levels of these
moleculesanddidnotexpresstypeIIFN.
We also included an additional IFN-
responsive gene ISG15 (IFN-stimulated
gene15)intheseassays.Consistentwitha
previous study of lipopolysaccharide
(LPS)-treated BMM and BMDC (41), we
foundthatCXCL10,IL-10,andISG15ex-
pression was dependent on IFNAR, but
notMyD88,signaling(Fig.5).TNF,IL-6,
and IL-12 p40 mRNA upregulation was
abolished in MHV-infected MyD88/
cells and was variably dependent upon
IFNAR signaling: the levels of IL-6 and
IL-12 p40 were decreased by about 50 to
80%inIFNAR/BMM(Fig.5AandB).
These mRNA data were conﬁrmed by
measuring the levels of CXCL10, TNF,
and IL-12 p70 protein in an ELISA
(Fig. 5C). As in MHV-infected cells,
CXCL10 expression in SenV-infected or
poly(I·C)-transfectedBMMwasalsode-
pendent on IFNAR, but not MyD88.
However, TNF expression in these sam-
ples was not dependent on MyD88, con-
sistent with a previous report showing
that TNF expression was mediated by di-
rect MDA5 recognition in SenV-infected
cells (Fig. 5A) (42). IL-6 and IL-12 p40
were expressed at very low levels in
poly(I·C)-treatedorSenV-infectedBMM,
so expression of these cytokines was not analyzed further.
Exogenous IFN enhances expression of cytokines and other
IFN-dependent molecules in MHV-infected BMM at early but
not late times p.i. Our results suggested that BMM expression of
several inﬂammation-related molecules, including IFN-/,
MDA5, RIG-I, and CXCL10, required signaling through the
IFNAR. However, from these results, it could not be determined
whether upregulated expression of these molecules occurred
solely as a consequence of MHV-induced IFN induction or if
some aspect of virus replication synergistically enhanced expres-
sion. Further, the amount of IFN produced in MHV-infected
BMM was much lower than in SenV-infected cells, raising ques-
tions as to whether this amount was sufﬁcient to fully upregulate
these IFN-induced genes. To address these questions, we treated
mock-infectedorMHV-infectedBMMwithIFN-andthenmea-
sured mRNA levels of inﬂammatory molecules by real-time
qPCR. The cells were treated with IFN- at 4 h p.i. to minimize
any effect that IFN treatment might have on virus replication; we
couldnotdetectanyMHV-inducedIFN-RNAorIFNproteinat
this time p.i. (Fig. 1C). We used a high dose of IFN (800 U of
murineIFN-)sothatanyIFN-mediatedeffectswouldbereadily
apparent. For comparison, we also treated mock- and MHV-
infected BMDC and 17Cl-1 cells with IFN, since IFN was barely
detected at any time p.i. in these cells. IFN treatment did not
reducevirustitersinanyofthesecells,whenmeasuredat16hp.i.
(Fig. 6A), consistent with previous reports (13, 32, 33).
To determine whether cytokine production by BMM required
virusreplication,weexposedBMMtoUV-inactivatedMHVpriorto
treatmentwithIFN-.IFN-treatmentdidnotstimulateexpression
FIG4 MHVinfectionresultsingreatercytokineandchemokineupregulationinBMMthaninBMDC.
BMM and BMDC were infected with MHV. (A) mRNA levels of CXCL10, CCL2, TNF, and IL-12 p40
were measured by real-time qPCR in BMM and BMDC at the indicated times p.i. ND, not detectable.
(B)BasallevelsofCXCL10,CCL2,andTNFweremeasuredbyreal-timeqPCRinmock-infectedBMM
and BMDC. CT ratios to HPRT are shown in panels A and B (note the differences in scale). In panels A
and B, three or four replicates were performed in each experiment, and one of three independent
experiments is shown. (C) Protein levels of TNF and IL-12 p70 in BMM were measured by ELISA at
differenttimesp.i.(D)ProteinlevelsofTNFandCXCL10inBMMandBMDCwereassayedat24hp.i.
In panels C and D, one of two independent experiments is shown. Values for BMDC that are signiﬁ-
cantly different from the value for BMM are indicated as follows: *, P  0.05; **, P  0.01.
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UV-inactivated virus, demonstrating that only active virus replica-
tion could initiate IFN-/ production (Fig. 6B). Treatment with
IFN- enhanced IFN production in MHV-infected BMM at 8 h p.i.
(Fig. 6B), which suggests that the levels of MHV-induced IFN were
insufﬁcienttomaximallyincreaseIFN-/expressionatthistimep.i.
However, by 16 h p.i., MHV induced sufﬁcient amounts of IFN so
that exogenous IFN had no additional effects (Fig. 6B). No IFN pro-
teinwasdetectedineitherMHV-infectedBMDCor17Cl-1cells(32,
43), but low levels of IFN mRNA were detected at late times p.i. in
these cells (23). Treatment of MHV-infected BMDC with IFN in-
duced signiﬁcantly (P0.01) higher levels of IFN-/mRNA than
didIFN-treatmentorMHVinfectionalone,whenmeasuredat16h
p.i., although the levels were only about 2% of those observed in
infected BMM. In 17Cl-1 cells, IFN-/ was expressed at very low
levelsafterinfection,evenafterIFN-treatment(Fig.6B).Combined
withdatageneratedfromIFNAR/BMM,theseresultssuggestthat
virus replication is required to initiate production of type I IFN,
which functions by autocrine signaling to reach maximal levels.
IFN-treatmentupregulatedexpressionofIFNAR-dependent
molecules MDA5, RIG-I, CXCL10, and ISG15 in mock-infected
BMM and BMDC to maximal levels as early as 4 h posttreatment,
andthelevelremainedconstantoverthenext8hours(Fig.6Cand
D). In contrast, expression of these molecules was minimal in
MHV-infectedBMMat8hp.i.butincreasedoverthefollowing12
to 16 h p.i. (Fig. 2B and C, 4A, and 6C and D). Exogenous IFN-
treatment enhanced expression of these molecules compared to
MHV infection alone at 8 but not 16 h p.i., again suggesting that
the amount of IFN produced by infected BMM was sufﬁcient for
maximal expression at later times p.i. (Fig. 6C and D). We de-
tected much higher mRNA levels of MDA5 and RIG-I in MHV-
infected BMM at 16 h p.i. than in IFN--treated mock-infected
cells, although the IFN level induced by MHV was actually lower
than 800 U (Fig. 1A and B). This likely occurred because MDA5
and RIG-I recognize viral PAMPs and directly upregulate expres-
sion of these IFN-dependent molecules via a positive-feedback
loop.Additionally,theseresultsalsosuggestthattheeffectsofIFN
on neighboring uninfected cells do not account for the elevated
levels of IFN, MDA5, and RIG-I detected in these cultures after
MHV infection, since the levels were substantially greater than
those observed after IFN treatment of mock-infected cells.
Incontrast,mRNAexpressionofMDA5,RIG-I,CXCL10,and
ISG15 was lower at 16 h p.i. in BMDC than after IFN treatment
alone (Fig. 6C and D). No IFN protein was produced at any time
after MHV infection in BMDC or 17Cl-1 cells, so exogenous IFN
greatly enhanced expression of these genes in both cell types. The
lowerlevelsobservedininfectedBMDCresultedonlyinpartfrom
an inability to produce IFN because even when we treated these
cells with IFN-, cytokine expression was still much lower than
detected in MHV-infected BMM (Fig. 6C and D). Furthermore,
virus replication and IFN acted synergistically only in enhancing
CXCL10 expression, with maximal levels obtained when MHV-
infected BMDC or 17Cl-1 cells were treated with IFN. Consistent
with analyses of IFNAR/ cells (Fig. 5A), TNF expression was
not upregulated by IFN treatment in any cell type in the presence
or absence of MHV infection (Fig. 6E).
Finally, we measured CXCL10 protein levels by an ELISA and, as
expected,observedincreasedproductionofCXCL10ininfectedcells.
However,CXCL10proteinlevelsinMHV-infectedBMMwerecom-
parable to those in IFN-treated mock-infected cells, even though
mRNA amounts in MHV-infected cells were appreciably higher at
16 h p.i. (compare Fig. 6D with Fig. 7A). IFN treatment of MHV-
infected BMM, BMDC, and 17Cl-1 cells did not increase CXCL10
protein production compared to IFN treatment alone. These results
FIG 5 MHV induces IFNAR-dependent and MyD88-dependent upregulation of cytokines and chemokines. (A) BMM isolated from WT, IFNAR/,o r
MyD88/miceweremockinfected,infectedwithMHVorSenV,ortransfectedwithpoly(I·C)for16h.mRNAlevelsofCXCL10andTNFweremeasuredby
real-time qPCR. (B) mRNA levels of IL-10, ISG15, IL-6, and IL-12 p40 in mock-infected or MHV-infected BMM isolated from WT, IFNAR/, or MyD88/
miceweremeasuredbyreal-timeqPCRat16hp.i.ND,notdetectable.CTratiostoHPRTareshowninpanelsAandB(notethedifferencesinscale).(C)Protein
levels of CXCL10, TNF, and IL-12 p70 were measured by ELISA. Two or three replicates were performed in each experiment, and one of two independent
experiments(forpanelC)oroneofthreeindependentexperiments(forpanelsAandB)isshown.Valuesthatarestatisticallysigniﬁcantlydifferentfromthevalue
for infected WT BMM are indicated as follows: *, P  0.05; **, P  0.01.
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mediated in part by nsp1 (11, 14, 34, 35). Of note, expression of the
MyD88-dependentmoleculeTNFwasnotupregulatedbyIFNtreat-
ment in mock-infected or MHV-infected cells (Fig. 7B), consistent
with the real-time qPCR data shown in Fig. 6E.
DISCUSSION
Theabilityofcoronavirusestoinduceaninterferonresponseinsome
cells and not others is not well understood. BMM and BMDC are
derived from the same BM progenitor cells in the presence of differ-
ent cytokines, but they show substantial differences in type I IFN
production and in cytokine and chemokine proﬁles (41, 44). Here,
we show that maximal IFN production in murine coronavirus-
infected BMM requires signaling through the IFNAR (Fig. 3C). We
coulddetectsmallamountsofIFNmRNAbutnotproteininMHV-
infected BMM at 8 h p.i. (Fig. 1). However, IFN may have been pro-
ducedatlowlevelsatthisearlytimep.i.butimmediatelydepletedby
binding to the IFNAR. In support of this, in a prior study, basal ex-
pressionofIFNbyBMMwasdetectedwhenIFNAR/butnotWT
BMM were examined by an ELISA (41). Together, these results sug-
gest that a very small amount of IFN produced initially following
infection effected a large increase in the levels of IFN and other in-
ﬂammatory molecules via autocrine signaling. However, treatment
of uninfected BMM with exogenous IFN did not induce the same
level of expression of some of these molecules as occurred in MHV-
infectedcellsat16hp.i.(Fig.6).Thus,activevirusreplicationinduced
cytokine and chemokine expression via additional pathways in
BMM. Furthermore, these molecules were largely produced by in-
fectedcellsandnotneighboringuninfected
cells.
It is likely that MDA5 is involved in
one or both steps of this ampliﬁcation
process, because MDA5 is expressed in
mock-infected BMM (Fig. 2), and previ-
ous work has shown that IFN expression
was signiﬁcantly decreased in MHV-
infectedMDA5/BMM(24).Thelevels
of MDA5 and RIG-I increased greatly af-
ter infection via an IFN-dependent path-
way, providing additional pathogen rec-
ognition receptors (PRRs) for detecting
virus replication products. By late times
FIG6 ExogenouslyaddedIFNisrequiredformaximallevelsofcytokineandchemokineexpressioninBMMat8hp.i.andinBMDCandﬁbroblastsat16hp.i.
BMM,BMDC,and17Cl-1cellswereinfectedwithMHV.Somesamplesweretreatedwith800UofIFN-at4hp.i.(A)Supernatantswereharvestedat16hp.i.,
andvirustitersweremeasured.(BtoE)RNAwaspreparedfrommock-infectedorMHV-infectedBMM,BMDC,or17Cl-1cellsat8or16hp.i.mRNAlevelsof
type I IFN (IFN- and IFN-4) (B), RNA helicases (MDA5 and RIG-I) (C), IFN-dependent genes (CXCL10 and ISG15) (D), and an IFN-independent gene
(TNF)(E)weremeasuredbyreal-timeqPCR.Todeterminewhetherupregulationrequiredactivevirusreplication,BMMwereexposedtoUV-inactivatedvirus
prior to IFN treatment, and the levels of select genes were determined (shown in the boxes to the right of the graph for BMM 16-h sample graphs). CT ratios to
HPRT are shown. All genes were induced to higher levels in BMM than in BMDC or 17Cl-1 cells (note the differences in scale). Three or four replicates were
performed in each experiment, and one of three independent experiments is shown. Values that were statistically signiﬁcantly different from the values for cells
infected with MHV and treated with IFN are indicated as follows: *, P  0.05; **, P  0.01.
FIG 7 Exogenously added IFN enhances expression of CXCL10 but not TNF. BMM, BMDC, and
17Cl-1 cells were infected with MHV with () or without () IFN- treatment at 4 h p.i. The levels of
CXCL10(A)andTNF(B)proteinweredeterminedbyanELISA.Oneoftwoindependentexperiments
is shown. Values that were signiﬁcantly different from the values for MHV-infected, IFN-treated cells
(P  0.01) are indicated (**).
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added IFN had no effect on the levels of any molecules that were
examined. Similar effects were observed in BMDC and 17Cl-1
ﬁbroblasts, but in these cells, no or very small amounts of IFN
mRNA (Fig. 6B) and no protein (18, 23, 32, 33) were produced
endogenously. Consequently, in both cell types, exogenous IFN
treatment signiﬁcantly upregulated expression of MDA5, RIG-I,
CXCL10, and ISG15. These results are consistent with recent re-
ports showing that IFN priming prior to tissue culture cell infec-
tion with SARS-CoV resulted in augmented expression of several
molecules involved in IFN induction and signaling pathways, in-
cluding CXCL10, RIG-I, MDA5, IRF-7, IFN-, ISG15, and 2=,5=-
oligoadenylate synthetase 1 (OAS1) (45). Analogous results were
obtained when human conventional DC were primed with IFN
prior to infection with inﬂuenza A virus (IAV) (46). Collectively,
our results suggest that IFN is critical for maximal expression of
these proinﬂammatory mediators, but unlike MHV-infected
BMDC or 17Cl-1 cells, sufﬁcient amounts of IFN are expressed
endogenouslyviaanMDA5-dependentpathwayininfectedBMM
to initiate the process.
TheenhancedresponsivenessofBMMcomparedtoBMDCor
ﬁbroblasts to MHV infection also occurs after exposure to other
stimuli. The levels of IFN-dependent proinﬂammatory cytokines
and chemokines, such as CCL2, CCL5, and CXCL10, were higher
in BMM than in BMDC after stimulation with LPS (44). This
increased sensitivity to MHV infection is not likely to be a func-
tion of differences in basal levels because baseline levels of MDA5
and RIG-I are only 2-fold higher in BMM than in BMDC
(Fig. 2A); both cell types should have responded nearly equiva-
lentlytoinfection,ifbasallevelsofMDA5weretheonlyfactor.On
the other hand, MDA5 levels are extremely low in 17Cl-1 cells
(Fig. 6C) (24), and this may have contributed to the inability of
these cells to produce IFN and other IFN-dependent proteins.
AnotherpossibleexplanationforthedifferenceinIFNexpression
in infected BMM compared to BMDC or ﬁbroblasts is that virus
replication could occur on different types of membranous struc-
tures in the different cell types. MHV is known to replicate on
double-membrane vesicles (DMV) and other intracellular mem-
branes (20). DMV may shield viral dsRNA from detection by
MDA5andRIG-I,sodifferencesinthenumbersofDMVorinthe
types of membranous structures used in replication could poten-
tially contribute to differences in PAMP recognition and subse-
quent IFN induction. However, we detected no obvious differ-
ences in the types of virus-speciﬁc membranous structures
observedinBMMcomparedtoothercellswhenanalyzedbyelec-
tron microscopy (data not shown); if anything, the numbers of
DMV in infected BMM were increased more than in other cells,
probablyreﬂectingthemorerapidcourseofinfectionobservedin
these cells (Fig. 1D). Thus, an outstanding question is how the
milieu of resting macrophages differs from those of BMDC and
ﬁbroblasts,enablingrapidandextensiveupregulationofIFN-/
and other proinﬂammatory molecules after infection with coro-
naviruses.
While a type I IFN ampliﬁcation loop is critical for maximal pro-
ductionofIFNandothermoleculessuchasCXCL10,someaspectsof
the innate response in MHV-infected BMM are not IFN dependent.
Thus, expression of TNF, IL-12, and IL-6 (Fig. 5) is completely de-
pendent upon signaling through MyD88. MyD88 is a key adaptor
molecule in signaling pathways used by IL-1, IL-18, and all of the
TLRs except TLR3. We examined the expression of TLR2, -3, -4, -6,
and-7andfoundthattheywereexpressedatlowlevelsinuninfected
BMM and upregulated after MHV infection (data not shown).
Therefore,signalingthroughoneofthesemoleculescouldinitiatethe
expression of these MyD88-dependent cytokines. In fact, IL-6 and
TNF production in peritoneal macrophages infected with the hepa-
totropicMHV-3strainisTLR2dependent(47).However,inprelim-
inary experiments, we detected the same levels of TNF and IL-6 in
MHV-A59-infected B6 and TLR2/ BMM, suggesting that TLR2
does not have the same critical role in BMM as observed in MHV-3-
infected peritoneal macrophages. Consistent with this putative cell-
speciﬁc difference in expression, splenic macrophages but not BMM
produce TNF in response to TLR2 ligands (48).
The relative importance of IFN production by macrophages
compared to pDC is not known in MHV-infected mice.
Cervantes-Barragan et al. showed that pDC depletion diminished
IFN- production by approximately 10-fold in mice with MHV-
inducedhepatitis(23).TypeIIFN-mediatedprotectionofMHV-
infected mice occurred via effects on macrophages and conven-
tional dendritic cells (cDC) because deletion of IFNAR from
macrophagesandcDCbutnotnonhematopoieticorotherhema-
topoietic cells resulted in severe liver disease (49). Thus, it is pos-
sible that IFN produced by infected macrophages at sites of infec-
tion is critical in protecting neighboring macrophages and DC
frominfectionandinprimingallcellsintheCNSandothersitesof
infection for subsequent IFN and cytokine production.
Taken together, our results show that macrophages, long con-
sidered a major target for infection with MHV, use both IFNAR-
dependentand-independentpathwaystoenhancetheinﬂamma-
tory milieu at sites of infection and that these pathways are
preferentially activated in these cells compared to DC or ﬁbro-
blasts. Combined with previous studies (50), they suggest that
macrophages are an attractive target for modulating the immune
response to enhance virus clearance while minimizing immuno-
pathological disease.
MATERIALS AND METHODS
Viruses and cell cultures. MHV-A59 (MHV) was grown on 17Cl-1 cells,
and the titers of the virus on HeLa cells expressing CEACAM1 (carcino-
embryonic antigen-related cell adhesion molecule 1), the MHV receptor
(51), were determined as previously described (52). The cells were in-
fectedwithMHVatamultiplicityofinfection(MOI)of5or,asacontrol,
with 100 hemagglutination activity units of Sendai virus (SenV) (Cantell
strain; Charles River Laboratories, Wilmington, MA). 17Cl-1 cells were
cultured in medium consisting of Dulbecco’s modiﬁed Eagle’s medium
(DMEM) supplemented with 5% fetal calf serum (FBS), 5% tryptose
phosphate, and 1% penicillin-streptomycin.
In some experiments, bone marrow-derived macrophages (BMM)
weretransfectedwith20g/mlpoly(I·C)(InvivoGen,SanDiego,CA)
using Lipofectamine 2000 (Invitrogen, Carlsbad, CA). In some exper-
iments,mock-infectedorMHV-infectedBMM,bonemarrow-derived
dendritic cells (BMDC), or 17Cl-1 cells were treated with 800 U of
murine IFN- (PBL Biomedical Laboratories, Piscataway, NJ) at 4 h
p.i.,andeithercells(mRNA)orsupernatants(protein)wereharvested
a t8ho r1 6hp . i .
Mice.Pathogen-freeC57BL/6micewerepurchasedfromtheNational
Cancer Institute (Frederick, MD). Mice deﬁcient in IFN-/ receptor
expression (IFNAR/) or in MyD88 expression (MyD88/) were
kindly provided by John Harty (University of Iowa, Iowa City, IA) or by
Shizuo Akira (Osaka University, Osaka, Japan) and Madhu Singh (Uni-
versity of Iowa, Iowa City, IA), respectively.
Generation of BMM and BMDC. Primary bone marrow cells were
isolated from the hind limbs of WT, IFNAR/, or MyD88/ C57BL/6
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mented with 10% FBS, 10% L929 cell-conditioned medium (as a source
for macrophage colony-stimulating factor [M-CSF]), 1 mM sodium
pyruvate,and1%penicillin-streptomycin.Thecellswereharvested7days
after plating and were 90% pure (CD11b CD11c–), as determined by
ﬂowcytometry.BMDCweregrowninRPMI1640mediumsupplemented
with 10% FBS, 1.0 mM HEPES, 0.2 mM L-glutamine, 1% penicillin-
streptomycin, 1 mM sodium pyruvate, 0.02 mM 2-mercaptoethanol,
1,000 U/ml recombinant granulocyte-macrophage colony-stimulating
factor(GM-CSF)(BDPharmingen,SanDiego,CA),and25U/mlrecom-
binant interleukin-4 (IL-4) (PeproTech, Rocky Hill, NJ). The cells were
used after 7 days of culture and were 80% pure (CD11b CD11c)a s
determined by ﬂow cytometry.
Real-timequantitativePCR(qPCR)analysis.RNAwasisolatedfrom
BMM, BMDC, or 17Cl-1 cells using Trizol (Invitrogen). The levels of
mRNA of genes of interest were determined by real-time qPCR as previ-
ously described (43). Primers are listed in Table 1. Cycle threshold (CT)
valueswerenormalizedtothevaluesforthehousekeepinggenehypoxan-
thinephosphoribosyltransferase(HPRT)bythefollowingequation:CT
CT (gene of interest)  CT (HPRT). All results are shown as a ratio to HPRT
calculated as 2CT.
IFNbioassay.ThelevelsofIFNweremeasuredusingabioassaybased
on the inhibition of vesicular stomatitis virus (VSV) growth in L929 cells.
Supernatants were harvested from infected BMM or BMDC, and infec-
tious virus was inactivated by exposure to UV light. L929 cells infected
with 10,000 PFU VSV were treated with dilutions of supernatants or de-
ﬁned amounts of recombinant murine IFN- at 30 min p.i. The titers of
VSV were determined on Vero cells. IFN levels were calculated on the
basis of standard curves generated with recombinant IFN-.
ELISA. To measure the protein levels of cytokines of interest, super-
natants were harvested from mock-infected or MHV-infected BMM or
BMDC and analyzed for CXCL10 (PBL Biomedical Laboratory) or IL-12
p70 or TNF (eBioscience, San Diego, CA) by an ELISA per the manufac-
turer’s instructions.
Statistics. A Student’s ttest was used to analyze differences in mean val-
ues between groups. All results are expressed as means  standard errors of
the means (SEM). Pvalues of 0.05 were considered statistically signiﬁcant.
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